Pathologic Outcomes of Laparoscopic vs Open Mesorectal Excision for Rectal Cancer: A Systematic Review and Meta-analysis
- PMID:28196217
- DOI: 10.1001/jamasurg.2016.5665
Pathologic Outcomes of Laparoscopic vs Open Mesorectal Excision for Rectal Cancer: A Systematic Review and Meta-analysis
Abstract
Importance: Rectal resection with mesorectal excision is the mainstay treatment for rectal cancer.
Objective: To review and analyze the evidence concerning the pathologic outcomes of laparoscopic (LRR) vs open (ORR) rectal resection for rectal cancer.
Data sources: The Cochrane Central Register of Controlled Trials, MEDLINE (through PubMed), EMBASE, Scopus databases, and clinicaltrials.gov were searched for randomized clinical trials (RCTs) comparing LRR vs ORR.
Study selection: Only RCTs published in English from January 1, 1995, to June 30, 2016, that compared LRR with ORR for histologically proven rectal cancer in adult patients and reported pathologic outcomes (eg, positive circumferential resection margin, and complete mesorectal excision) were eligible for inclusion. Of 369 records screened, 14 RCTs were selected for the qualitative and quantitative analyses.
Data extraction and synthesis: Two independent reviewers performed the study selection and quality assessment. Random-effects models were used to summarize the risk ratio (RR) and mean differences.
Main outcomes and measures: The rate of positive circumferential resection margin (CRM), defined as 1 mm or less from the closest tumor to the cut edge of the tissue, and the quality of mesorectal excision (complete, nearly complete, or incomplete).
Results: The meta-analysis included 14 unique RCTs with 4034 unique patients. Of 2989 patients undergoing rectal resection, a positive CRM was found in 135 (7.9%) of 1697 patients undergoing LRR and 79 (6.1%) of 1292 patients undergoing ORR (RR, 1.17; 95% CI, 0.89-1.53; P = .26; I2 = 0%) in 9 studies. A noncomplete (nearly complete and incomplete) mesorectal excision was reported in 179 (13.2%) of 1354 patients undergoing LRR and 104 (10.4%) of 998 patients undergoing ORR (RR, 1.31; 95% CI, 1.05-1.64; P = .02; I2 = 0%) in 5 studies. The distal resection margin involvement (RR, 1.12; 95% CI, 0.34-3.67; P = .86), the mean number of lymph nodes retrieved (mean difference, 0.05; 95% CI, -0.77 to 0.86; P = .91), the mean distance to the distal margin (mean difference, 0.01 cm; 95% CI, -0.12 to 0.15 cm; P = .87), and the mean distance to radial margins (mean difference, -0.67 mm; 95% CI, -2.16 to 0.83 mm; P = .38) were not significantly different between LRR and ORR. The risk for bias was assessed as low in 10 studies, high in 3, and unknown in 1. The overall quality of the evidence emerging from the literature was rated as high.
Conclusions and relevance: Based on the available evidence, the risk for achieving a noncomplete mesorectal excision is significantly higher in patients undergoing LRR compared with ORR. These findings question the oncologic safety of laparoscopy for the treatment of rectal cancer. However, long-term results of the ongoing RCTs are awaited to assess whether these pathologic results have an effect on disease-free and overall patient survival.
Comment in
- Which Surgical Approach Is Best for Management of Rectal Cancer?: Does the End Point Tell How It Ends?Sandhu L, Chang GJ.Sandhu L, et al.JAMA Surg. 2017 Apr 19;152(4):e165659. doi: 10.1001/jamasurg.2016.5659. Epub 2017 Apr 19.JAMA Surg. 2017.PMID:28196188No abstract available.
- Pathologic Outcomes of Laparoscopic vs Open Mesorectal Excision for Rectal Cancer.Koedam TWA, Bonjer HJ, Lacy AM.Koedam TWA, et al.JAMA Surg. 2017 Oct 1;152(10):986. doi: 10.1001/jamasurg.2017.1723.JAMA Surg. 2017.PMID:28658463No abstract available.
- Pathologic Outcomes of Laparoscopic vs Open Mesorectal Excision for Rectal Cancer.Acuna SA, Chesney TR, Baxter NN.Acuna SA, et al.JAMA Surg. 2017 Oct 1;152(10):986-987. doi: 10.1001/jamasurg.2017.1724.JAMA Surg. 2017.PMID:28658479No abstract available.
- Pathologic Outcomes of Laparoscopic vs Open Mesorectal Excision For Rectal Cancer-Reply.de'Angelis N, Martínez-Pérez A, Brunetti F.de'Angelis N, et al.JAMA Surg. 2017 Oct 1;152(10):987-988. doi: 10.1001/jamasurg.2017.1725.JAMA Surg. 2017.PMID:28658481No abstract available.
- [Pathologic results after laparoscopic and open surgery for rectal cancer].Reibetanz J, Germer CT.Reibetanz J, et al.Chirurg. 2017 Aug;88(8):709. doi: 10.1007/s00104-017-0474-4.Chirurg. 2017.PMID:28695224German.No abstract available.
Similar articles
- Laparoscopic vs. open mesorectal excision for rectal cancer: Are these approaches still comparable? A systematic review and meta-analysis.Conticchio M, Papagni V, Notarnicola M, Delvecchio A, Riccelli U, Ammendola M, Currò G, Pessaux P, Silvestris N, Memeo R.Conticchio M, et al.PLoS One. 2020 Jul 28;15(7):e0235887. doi: 10.1371/journal.pone.0235887. eCollection 2020.PLoS One. 2020.PMID:32722694Free PMC article.
- Short-term clinical outcomes of laparoscopic vs open rectal excision for rectal cancer: A systematic review and meta-analysis.Martínez-Pérez A, Carra MC, Brunetti F, de'Angelis N.Martínez-Pérez A, et al.World J Gastroenterol. 2017 Nov 28;23(44):7906-7916. doi: 10.3748/wjg.v23.i44.7906.World J Gastroenterol. 2017.PMID:29209132Free PMC article.Review.
- Laparoscopic versus open surgery for rectal cancer: A meta-analysis of classic randomized controlled trials and high-quality Nonrandomized Studies in the last 5 years.Chen K, Cao G, Chen B, Wang M, Xu X, Cai W, Xu Y, Xiong M.Chen K, et al.Int J Surg. 2017 Mar;39:1-10. doi: 10.1016/j.ijsu.2016.12.123. Epub 2017 Jan 11.Int J Surg. 2017.PMID:28087370Review.
- Outcomes of open vs laparoscopic vs robotic vs transanal total mesorectal excision (TME) for rectal cancer: a network meta-analysis.Seow W, Dudi-Venkata NN, Bedrikovetski S, Kroon HM, Sammour T.Seow W, et al.Tech Coloproctol. 2023 May;27(5):345-360. doi: 10.1007/s10151-022-02739-1. Epub 2022 Dec 12.Tech Coloproctol. 2023.PMID:36508067Review.
- There is no difference in outcome between laparoscopic and open surgery for rectal cancer: a systematic review and meta-analysis on short- and long-term oncologic outcomes.Pędziwiatr M, Małczak P, Mizera M, Witowski J, Torbicz G, Major P, Pisarska M, Wysocki M, Budzyński A.Pędziwiatr M, et al.Tech Coloproctol. 2017 Aug;21(8):595-604. doi: 10.1007/s10151-017-1662-4. Epub 2017 Aug 9.Tech Coloproctol. 2017.PMID:28795243Free PMC article.Review.
Cited by
- Short- and long-term outcomes of robotic-assisted laparoscopic surgery for rectal cancer: results of a single high-volume center in Japan.Yamaguchi T, Kinugasa Y, Shiomi A, Kagawa H, Yamakawa Y, Furuatni A, Manabe S, Yamaoka Y, Hino H.Yamaguchi T, et al.Int J Colorectal Dis. 2018 Dec;33(12):1755-1762. doi: 10.1007/s00384-018-3153-0. Epub 2018 Sep 6.Int J Colorectal Dis. 2018.PMID:30191369
- Comparison of Survival Among Adults With Rectal Cancer Who Have Undergone Laparoscopic vs Open Surgery: A Meta-analysis.Kong M, Chen H, Shan K, Sheng H, Li L.Kong M, et al.JAMA Netw Open. 2022 May 2;5(5):e2210861. doi: 10.1001/jamanetworkopen.2022.10861.JAMA Netw Open. 2022.PMID:35532937Free PMC article.
- Predictors of surgical outcomes and survival in rectal cancer patients undergoing laparoscopic total mesorectal excision after neoadjuvant chemoradiation therapy: the interest of pelvimetry and restaging magnetic resonance imaging studies.de'Angelis N, Pigneur F, Martínez-Pérez A, Vitali GC, Landi F, Torres-Sánchez T, Rodrigues V, Memeo R, Bianchi G, Brunetti F, Espin E, Ris F, Luciani A; EuMaRCS Study Group.de'Angelis N, et al.Oncotarget. 2018 May 18;9(38):25315-25331. doi: 10.18632/oncotarget.25431. eCollection 2018 May 18.Oncotarget. 2018.PMID:29861874Free PMC article.
- Laparoscopic versus open surgery in obstructive colorectal cancer patients following stents placement: a comprehensive meta-analysis of cohort studies.Zeng K, Zhang F, Yang H, Zha X, Fang S.Zeng K, et al.Surg Endosc. 2024 Apr;38(4):1740-1757. doi: 10.1007/s00464-024-10710-4. Epub 2024 Mar 5.Surg Endosc. 2024.PMID:38443501Free PMC article.Review.
- Robotic versus laparoscopic versus open colorectal surgery: towards defining criteria to the right choice.Zelhart M, Kaiser AM.Zelhart M, et al.Surg Endosc. 2018 Jan;32(1):24-38. doi: 10.1007/s00464-017-5796-2. Epub 2017 Aug 15.Surg Endosc. 2018.PMID:28812154Review.
Publication types
MeSH terms
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources